Y. Komarova and A. Malik, Regulation of endothelial permeability via paracellular and transcellular transport pathways. Annual review of physiology, pp.463-493, 2010.

E. Dejana and C. Giampietro, Vascular endothelial-cadherin and vascular stability. Current opinion in hematology, pp.218-223, 2012.
DOI : 10.1097/moh.0b013e3283523e1c

L. Goddard and M. Iruela-arispe, Cellular and molecular regulation of vascular permeability, Thrombosis and Haemostasis, vol.109, issue.3, pp.407-415, 2013.
DOI : 10.1160/TH12-09-0678

M. Giannotta, M. Trani, and E. Dejana, VE-Cadherin and Endothelial Adherens Junctions: Active Guardians of Vascular Integrity, Developmental Cell, vol.26, issue.5, pp.441-454, 2013.
DOI : 10.1016/j.devcel.2013.08.020

P. Kumar, Q. Shen, C. Pivetti, E. Lee, M. Wu et al., Molecular mechanisms of endothelial hyperpermeability: implications in inflammation, Expert Reviews in Molecular Medicine, vol.160, pp.19-25, 2009.
DOI : 10.1165/rcmb.2002-0085OC

A. Mackenzie, Endothelium-derived vasoactive agents, AT1 receptors and inflammation, Pharmacology & Therapeutics, vol.131, issue.2, pp.187-203, 2011.
DOI : 10.1016/j.pharmthera.2010.11.001

S. Fisher, Vascular smooth muscle phenotypic diversity and function, Physiological Genomics, vol.42, issue.3, pp.169-187, 2010.
DOI : 10.1152/physiolgenomics.00111.2010

A. Armulik, G. Genove, and C. Betsholtz, Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises, Developmental Cell, vol.21, issue.2, pp.193-215, 2011.
DOI : 10.1016/j.devcel.2011.07.001

URL : http://doi.org/10.1016/j.devcel.2011.07.001

F. Simons, A. Sheikh, M. Ben-shoshan, and A. Clarke, Anaphylaxis: The acute episode and beyond Anaphylaxis: Past, present and future, Bmj. Allergy, vol.34666, issue.10, pp.1-14, 2011.

D. Metcalfe, R. Peavy, and A. Gilfillan, Mechanisms of mast cell signaling in anaphylaxis. The Journal of allergy and clinical immunology, pp.639-646, 2009.

H. Rodewald, T. Feyerabend, S. Brown, S. Stone, D. Fatovich et al., Widespread immunological functions of mast cells: Fact or fiction? Anaphylaxis: Clinical patterns, mediator release, and severity. The Journal of allergy and clinical immunology Voehringer D. Protective and pathological roles of mast cells and basophils, Immunity. Nature reviews. Immunology. Moon TC, vol.3713213, pp.13-24, 2012.

T. Theoharides, K. Alysandratos, A. Angelidou, D. Delivanis, N. Sismanopoulos et al., Mast cells and inflammation, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol.1822, issue.1, pp.21-33, 2012.
DOI : 10.1016/j.bbadis.2010.12.014

M. Triggiani, V. Patella, R. Staiano, F. Granata, and G. Marone, Allergy and the cardiovascular system, Clinical & Experimental Immunology, vol.110, issue.1, pp.7-11, 2008.
DOI : 10.1111/j.1365-2249.2008.03714.x

R. Peavy and D. Metcalfe, Understanding the mechanisms of anaphylaxis, Current Opinion in Allergy and Clinical Immunology, vol.8, issue.4, pp.310-315, 2008.
DOI : 10.1097/ACI.0b013e3283036a90

S. Panesar, S. Javad, D. De-silva, B. Nwaru, L. Hickstein et al., The epidemiology of anaphylaxis in Europe: a systematic review, Allergy, vol.27, issue.3, pp.1353-1361, 2013.
DOI : 10.1111/all.12272

T. Varga, Z. Czimmerer, and L. Nagy, PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol.1812, issue.8, pp.1007-1022, 2011.
DOI : 10.1016/j.bbadis.2011.02.014

URL : https://hal.archives-ouvertes.fr/hal-00706534

L. Poulsen, M. Siersbaek, and S. Mandrup, Ppars: Fatty acid sensors controlling metabolism. Seminars in cell & developmental biology, pp.631-639, 2012.

W. Wahli and L. Michalik, Ppars at the crossroads of lipid signaling and inflammation. Trends in endocrinology and metabolism: TEM, pp.351-363, 2012.

C. Lamers, M. Schubert-zsilavecz, and D. Merk, Therapeutic modulators of peroxisome proliferator-activated receptors (ppar): A patent review (2008-present) Expert opinion on therapeutic patents, pp.803-841, 2012.

J. Madrazo and D. Kelly, The ppar trio: Regulators of myocardial energy metabolism in health and disease Peroxisome proliferator-activated receptor delta: A multifaceted metabolic player, J Mol Cell Cardiol Current opinion in lipidology, vol.24, pp.171-177, 2013.

Y. Barak, Y. Sadovsky, and T. Shalom-barak, PPAR Signaling in Placental Development and Function, PPAR Research, vol.129, issue.12, pp.142082-142111, 2008.
DOI : 10.1083/jcb.151.3.563

B. Abbott, K. Nadra, S. Anghel, J. E. Tan, N. Basu-modak et al., beta (ppar beta), and gamma (ppar gamma) in rodent and human development Differentiation of trophoblast giant cells and their metabolic functions are dependent on peroxisome proliferator-activated receptor beta/delta, Reprod Toxicol. Molecular and cellular biology, vol.2726, issue.30, pp.246-2573266, 2006.

A. Montagner, G. Rando, G. Degueurce, N. Leuenberger, L. Michalik et al., New insights into the role of PPARs, Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA), vol.85, issue.5, pp.235-243, 2011.
DOI : 10.1016/j.plefa.2011.04.016

L. Michalik, W. Wahli, A. Montagner, M. Delgado, C. Tallichet-blanc et al., Src is activated by the nuclear receptor peroxisome proliferator-activated receptor beta/delta in ultraviolet radiation-induced skin cancer. EMBO molecular medicine The nuclear hormone receptor peroxisome proliferator-activated receptor beta/delta potentiates cell chemotactism, polarization, and migration, International Congress Series Mol Cell Biol, vol.130227, issue.34, pp.45-52, 2007.

L. Michalik and N. Tan, Regulation of epithelial-mesenchymal il-1 signaling by pparbeta/delta is essential for skin homeostasis and wound healing, J Cell Biol, vol.184, pp.817-831, 2009.

S. Duan, M. Usher, and R. Mortensen, PPARs: the vasculature, inflammation and hypertension, Current Opinion in Nephrology and Hypertension, vol.18, issue.2, pp.128-1331601, 2009.
DOI : 10.1097/MNH.0b013e328325803b

J. Plutzky, The ppar-rxr transcriptional complex in the vasculature: Energy in the balance. Circulation research, pp.1002-1016, 2011.

W. Cheang, X. Fang, and X. Tian, Pleiotropic Effects of Peroxisome Proliferator-Activated Receptor ^|^gamma; and ^|^delta; in Vascular Diseases, Circulation Journal, vol.77, issue.11, pp.2664-2671, 2013.
DOI : 10.1253/circj.CJ-13-0647

E. Gustafsson, C. Brakebusch, K. Hietanen, and R. Fassler, Tie-1-directed expression of cre recombinase in endothelial cells of embryoid bodies and transgenic mice, Journal of cell science, vol.114, pp.671-676, 2001.

M. Schuler, F. Ali, C. Chambon, D. Duteil, J. Bornert et al., PGC1?? expression is controlled in skeletal muscles by PPAR??, whose ablation results in fiber-type switching, obesity, and type 2 diabetes, Cell Metabolism, vol.4, issue.5, pp.407-414, 2006.
DOI : 10.1016/j.cmet.2006.10.003

J. Iglesias, S. Barg, D. Vallois, S. Lahiri, C. Roger et al., Pparbeta/delta affects pancreatic beta cell mass and insulin secretion in mice Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin e receptor alpha chain gene, The Journal of clinical investigation. Cell, vol.12275, pp.4105-4117, 1993.

E. Mazuc, B. Villoutreix, O. Malbec, T. Roumier, S. Fleury et al., A novel druglike spleen tyrosine kinase binder prevents anaphylactic shock when administered orally, Journal of Allergy and Clinical Immunology, vol.122, issue.1, pp.188-194, 2008.
DOI : 10.1016/j.jaci.2008.04.026

URL : https://hal.archives-ouvertes.fr/inserm-00292498

J. Hellemans, G. Mortier, D. Paepe, A. Speleman, F. Vandesompele et al., Qbase relative quantification framework and software for management and automated analysis of real-time quantitative pcr data, Genome Biology, vol.8, issue.2, pp.19-46, 2007.
DOI : 10.1186/gb-2007-8-2-r19

D. Dombrowicz, S. Lin, V. Flamand, A. Brini, B. Koller et al., Allergy-Associated FcR?? Is a Molecular Amplifier of IgE- and IgG-Mediated In Vivo Responses, Immunity, vol.8, issue.4, pp.517-529, 1998.
DOI : 10.1016/S1074-7613(00)80556-7

J. Han, H. Lee, H. Yang, J. Hur, S. Jun et al., Peroxisome Proliferator-Activated Receptor-?? Agonist Enhances Vasculogenesis by Regulating Endothelial Progenitor Cells Through Genomic and Nongenomic Activations of the Phosphatidylinositol 3-Kinase/Akt Pathway, Circulation, vol.118, issue.10, pp.1021-1033, 2008.
DOI : 10.1161/CIRCULATIONAHA.108.777169

S. Muller-brusselbach, M. Komhoff, M. Rieck, W. Meissner, K. Kaddatz et al., Deregulation of tumor angiogenesis and blockade of tumor growth in pparbeta-deficient mice. The EMBO journal, pp.3686-3698, 2007.

P. Hahnfeldt, L. Hlatky, J. Debus, J. Peters, H. Friess et al., Transcriptional network governing the angiogenic switch in human pancreatic cancer, Proceedings of the National Academy of Sciences of the United States of America, vol.104, pp.12890-12895, 2007.

M. Khazaei, E. Salehi, B. Rashidi, S. Javanmard, and A. Fallahzadeh, Role of peroxisome proliferator-activated receptor ?? agonist on angiogenesis in hindlimb ischemic diabetic rats, Journal of Diabetes and its Complications, vol.26, issue.2, pp.137-140, 2012.
DOI : 10.1016/j.jdiacomp.2012.02.005

Y. Takata, J. Liu, F. Yin, A. Collins, C. Lyon et al., Ppar{delta}-mediated antiinflammatory mechanisms inhibit angiotensin ii-accelerated atherosclerosis, Proceedings of the National Academy of Sciences of the United States of America, 2008.
DOI : 10.1073/pnas.0708647105

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2393800

M. Meissner, I. Hrgovic, M. Doll, J. Naidenow, G. Reichenbach et al., Peroxisome Proliferator-activated Receptor ?? Activators Induce IL-8 Expression in Nonstimulated Endothelial Cells in a Transcriptional and Posttranscriptional Manner, Journal of Biological Chemistry, vol.285, issue.44, pp.33797-33804, 2010.
DOI : 10.1074/jbc.M110.137943

H. Lim, S. Lee, J. Park, K. Lee, H. Choi et al., PPAR?? agonist L-165041 inhibits rat vascular smooth muscle cell proliferation and migration via inhibition of cell cycle, Atherosclerosis, vol.202, issue.2, pp.446-454, 2009.
DOI : 10.1016/j.atherosclerosis.2008.05.023

H. Seo, Ppardelta inhibits il-1beta-stimulated proliferation and migration of vascular smooth muscle cells via up-regulation of il-1ra. Cellular and molecular life sciences, CMLS, vol.67, pp.2119-2130, 2010.

L. Piqueras, M. Sanz, M. Perretti, E. Morcillo, L. Norling et al., Activation of ppar{beta}/{delta} inhibits leukocyte recruitment, cell adhesion molecule expression, and chemokine release, J Leukoc Biol, 200921.

L. Bojic, A. Burke, S. Chhoker, D. Telford, B. Sutherland et al., Peroxisome proliferator-activated receptor delta agonist gw1516 attenuates diet-induced aortic inflammation, insulin resistance, and atherosclerosis in low-density lipoprotein receptor knockout mice. Arteriosclerosis, thrombosis, and vascular biology, pp.52-60, 2014.

J. Mitchell, R. Jimenez, M. Sanchez, M. Zarzuelo, M. Romero et al., The pparbeta/delta agonist gw0742 relaxes pulmonary vessels and limits right heart hypertrophy in rats with hypoxia-induced pulmonary hypertension, PloS one, vol.5, pp.9526-59, 2010.

M. Zarzuelo, R. Jimenez, P. Galindo, M. Sanchez, A. Nieto et al., Antihypertensive Effects of Peroxisome Proliferator-Activated Receptor-?? Activation in Spontaneously Hypertensive Rats, Hypertension, vol.58, issue.4, pp.733-743, 2011.
DOI : 10.1161/HYPERTENSIONAHA.111.174490

H. Aramoto, J. Breslin, P. Pappas, R. Hobson, and W. Duran, Vascular endothelial growth factor stimulates differential signaling pathways in in vivo microcirculation, AJP: Heart and Circulatory Physiology, vol.287, issue.4
DOI : 10.1152/ajpheart.00767.2003

J. Breslin, P. Pappas, J. Cerveira, R. Hobson, and W. Duran, Vegf increases endothelial permeability by separate signaling pathways involving erk-1/2 and nitric oxide American journal of physiology. Heart and circulatory physiology Vegf increases permeability of the endothelial cell monolayer by activation of pkb/akt, endothelial nitric-oxide synthase, and map kinase pathways, Microvascular research, vol.28462, issue.64, pp.92-100252, 2001.

V. Spindler, N. Schlegel, and J. Waschke, Role of gtpases in control of microvascular permeability. Cardiovascular research, pp.243-253, 2010.

E. Dejana, F. Orsenigo, M. Lampugnani, R. Paul, Z. Zhang et al., The role of adherens junctions and vecadherin in the control of vascular permeability Src deficiency or blockade of src activity in mice provides cerebral protection following stroke, Journal of cell science. Nature medicine, vol.1217, pp.2115-2122, 2001.

S. Weis, S. Shintani, A. Weber, R. Kirchmair, M. Wood et al., Src blockade stabilizes a flk/cadherin complex, reducing edema and tissue injury following myocardial infarction. The Journal of clinical investigation, pp.885-894, 2004.

B. Eliceiri, X. Puente, J. Hood, D. Stupack, D. Schlaepfer et al., Src-mediated coupling of focal adhesion kinase to integrin alpha(v)beta5 in vascular endothelial growth factor signaling Peroxisome proliferator-activated receptors beta/delta: Emerging roles for a previously neglected third family member Activation of ppardelta prevents endothelial dysfunction induced by overexpression of amyloid-beta precursor protein. Cardiovascular research Activation of peroxisome proliferator-activated receptor-beta/-delta (pparbeta/delta) prevents endothelial dysfunction in type 1 diabetic rats Free radical biology & medicine, The Journal of cell biology. Curr Opin Lipidol. Quintela AM, vol.157149653, issue.70, pp.149-160129, 2002.

X. Tian, W. Wong, N. Wang, Y. Lu, W. Cheang et al., PPAR?? Activation Protects Endothelial Function in Diabetic Mice, Diabetes, vol.61, issue.12, pp.3285-3293, 2012.
DOI : 10.2337/db12-0117

A. Santhanam, L. Uscio, T. He, and Z. Katusic, PPAR?? agonist GW501516 prevents uncoupling of endothelial nitric oxide synthase in cerebral microvessels of hph-1 mice, Brain Research, vol.1483, pp.89-95, 2012.
DOI : 10.1016/j.brainres.2012.09.012

R. Huegel, P. Velasco, D. , L. Sierra, M. Christophers et al., Novel Anti-Inflammatory Properties of the Angiogenesis Inhibitor Vasostatin, Journal of Investigative Dermatology, vol.127, issue.1, pp.65-74, 2007.
DOI : 10.1038/sj.jid.5700484

M. Detmar, Inhibition of chronic and acute skin inflammation by treatment with a vascular endothelial growth factor receptor tyrosine kinase inhibitor. The American journal of pathology, pp.265-277, 2008.

P. Velasco, R. Huegel, J. Brasch, J. Schroder, M. Weichenthal et al., The Angiogenesis Inhibitor Thrombospondin-1 Inhibits Acute Cutaneous Hypersensitivity Reactions, Journal of Investigative Dermatology, vol.129, issue.8, pp.2022-2030, 2009.
DOI : 10.1038/jid.2008.447

P. Friedl, D. Zinkl, R. Hofer-warbinek, K. Zacharowski, P. Petzelbauer et al., Peptide bbeta(15-42) preserves endothelial barrier function in shock Endothelial barrier stabilization by a cyclic tandem peptide targeting ve-cadherin transinteraction in vitro and in vivo, PloS one. Journal of cell science, vol.4122, pp.5391-801616, 2009.

P. Carmeliet and R. Jain, Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases, Nature Reviews Drug Discovery, vol.7, issue.6, pp.417-427, 2011.
DOI : 10.1038/nrd3455